{"id":17375,"date":"2022-11-17T14:51:13","date_gmt":"2022-11-17T13:51:13","guid":{"rendered":"http:\/\/mabdesign.fr\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/"},"modified":"2022-11-17T14:51:13","modified_gmt":"2022-11-17T13:51:13","slug":"alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/","title":{"rendered":"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress"},"content":{"rendered":"

Paris, France, November 2, 2022 \u2013\u00a0<\/strong>Alderaan Biotechnology, a preclinical stage biotech company focused on monoclonal antibody development for the treatment of cancer, today announces it will present the most recent development\u00a0of its new antibody candidate ALD2510 at the\u00a0Society for Immunotherapy of Cancer\u2019s (SITC) 37th<\/sup>\u00a0Annual Meeting<\/a> on November 8-12, 2022, in Boston (MA, USA). The poster will cover its promising preclinical results on tolerability and manufacturability, as well as the potential of the antibody in the treatment of gynecologic and breast cancers. To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-17375","post","type-post","status-publish","format-standard","hentry","category-news","category-our-members"],"yoast_head":"\nAlderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress - MabDesign<\/title>\n<meta name=\"description\" content=\"Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-17T13:51:13+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress\",\"datePublished\":\"2022-11-17T13:51:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\"},\"wordCount\":98,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\",\"name\":\"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2022-11-17T13:51:13+00:00\",\"description\":\"Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress - MabDesign","description":"Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/","og_locale":"en_US","og_type":"article","og_title":"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress - MabDesign","og_description":"Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.","og_url":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/","og_site_name":"MabDesign","article_published_time":"2022-11-17T13:51:13+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress","datePublished":"2022-11-17T13:51:13+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/"},"wordCount":98,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/","url":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/","name":"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2022-11-17T13:51:13+00:00","description":"Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/alderaan-biotechnology-presents-latest-developments-in-next-generation-anti-cd25-antibody-at-sitc-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17375"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17375\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}